The calcium-sensing receptor and vitamin D receptor expression in tertiary hyperparathyroidism

International Journal of Molecular Medicine

Volumn 17, Issue 5, 2006, Pages 779-783

  Grzela, Tomasz ^a   Chudzinski, Witold ^b   Lasiecka, Zofia ^c   Niderla, Justyna ^a   Wilczynski, Grzegorz ^c   Gornicka, Barbara ^c   Wasiutynski, Aleksander ^c   Durlik, Magdalena ^c   Boszczyk, Anna ^a   Brawura Biskupski Samaha, Robert ^a   Dziunycz, Piotr ^a   Milewski, Lukasz ^a   Lazarczyk, Marta ^a   Lazarczyk, Maciej ^a   Nawrot, Ireneusz ^b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b Central University Hospital   (Poland)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Calcium sensing receptor; Parathyroid gland; Tertiary hyperparathyroidism; Vitamin D receptor

Indexed keywords

CALCITRIOL RECEPTOR; CALCIUM SENSING RECEPTOR;

ADULT; ARTICLE; BIOSYNTHESIS; CHEMISTRY; FEMALE; HUMAN; HYPERPARATHYROIDISM; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; PARATHYROID GLAND; PATHOLOGY; WESTERN BLOTTING;

ADULT; BLOTTING, WESTERN; FEMALE; HUMANS; HYPERPARATHYROIDISM; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PARATHYROID GLANDS; RECEPTORS, CALCITRIOL; RECEPTORS, CALCIUM-SENSING;

EID: 33750594927     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.17.5.779     Document Type: Article

References (22)

1. Chen R and Goodman W: Role of the calcium-sensing receptor in parathyroid gland physiology. Am J Physiol Renal Physiol 286: 1005-1011, 2004.
2. Ruat M and Petrel C: New insights into the pharmacology of the extracellular calcium sensing receptor. Med Sci 20: 980-985, 2004.
3. Wada M, Furuya Y, Sakiyama J, Kobayashi N, Miyata S, Ishii H and Nagano N: The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency. Control of parathyroid cell growth via a calcium receptor. J Clin Invest 100: 2977-2983, 1997.
4. Thakker R: Diseases associated with the extracellular calcium-sensing receptor. Cell Calcium 35: 275-282, 2004.
5. Pramanik R, Asplin JR, Lindeman C, Favus MJ, Bai S and Coe FL: Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells. Cell Immunol 232: 137-143, 2004.
6. Sunn KL, Cock TA, Crofts LA, Eisman JA and Gardinger EM: Novel N-terminal variant of human VDR. Mol Endocrinol 15: 1599-1609, 2001.
7. Llach F: Secondary hyperparathyroidism in renal failure: the trade-off hypothesis revisited. Am J Kidney Dis 25: 663-679, 1995.
8. Koch Nogueira PC, David L and Cochat P: Evolution of secondary hyperparathyroidism after renal transplantation. Pediatr Nephrol 14: 342-346, 2000.
9. Younes NA, Shafagoy Y, Khatib S and Ababneh M: Laboratory screening for hyperparathyroidism. Clin Chim Acta 353: 1-12, 2005.
10. Kwak JO, Kwak J, Kim HW, Oh KJ, Kim YT, Yung SM and Cha SH: The extracellular calcium sensing receptor is expressed in mouse mesangial cells and modulates cell proliferation. Exp Mol Med 37: 457-465, 2005.
11. Rodriguez M, Nemeth E and Martin D: The calcium-sensing receptor: a key factor in pathogenesis of secondary hyperparathyroidism. Am J Physiol Renal Physiol 288: 253-264, 2005.
12. Brown EM: Physiology and pathophysiology of the extracellular calcium-sensing receptor. Am J Med 106: 238-253, 1999.
13. Sudhaker Rao D, Han ZH, Phillips ER, Palnitkar S and Parfitt AM: Reduced vitamin D receptor expression in parathyroid adenomas: implications for pathogenesis. Clin Endocrinol 53: 373-381, 2000.
14. Grimelius L, Akerstrom G, Bondeson L, Juhlin C, Johansson H, Ljunghall S and Rastad J: The role of the pathologist in diagnosis and surgical decision making in hyperparathyroidism. World J Surg 15: 698-705, 1991.
15. Lazarczyk M, Dziunycz P, Niderla J, et al: Influence of pentoxifylline on natural cytotoxicity and expression of granzymes and PI-9, a specific granzyme B inhibitor. Int J Mol Med 17: 135-140, 2006.
16. Chudzinski W, Niderla J, Lasiecka Z, et al: P-glycoprotein expression influences the result of 99mTc-MIBI scintigraphy in tertiary hyperparathyroidism. Int J Mol Med 16: 215-220, 2005.
17. Dusso AS, Thadhani R and Slatopolsky Y: Vitamin D receptor and analogs. Semin Nephrol 24: 10-16, 2004.
18. Yano S, Sugimoto T, Tsukamoto T, et al: Association of decreased calcium-sensing receptor expression with proliferation of parathyroid cells in secondary hyperparathyroidism. Kidney Int 58: 1980-1986, 2000.
19. Kifor O, Kifor I, Moore FD, Butters RR and Brown EM: M-calpain colocalizes with the calcium-sensing receptor (CaR) in caveolae in parathyroid cells and participates in degradation of the CaR. J Biol Chem 33: 31167-31176, 2003.
20. Healy KD, Vanhooke JL, Prahl JM and DeLuca HF: Parathyroid hormone decreases renal vitamin D receptor expression in vivo. Proc Natl Acad Sci USA 102: 4724-4728, 2005.
21. Mizobuch M, Hatamura I, Ogata H, et al: Calcimimetic compound upregulates decreased calcium-sensing receptor expression level in parathyroid glands of rats with chronic renal insufficiency. J Am Soc Nephrol 15: 2579-2587, 2004.
22. Giannini S, D'Angelo A, Nobile M, et al: The effects of vitamin D receptor polymorphism on secondary hyperparathyroidism and bone density after renal transplantation. J Bone Miner Res 17: 1768-1773, 2002.